Results 41 to 50 of about 661,169 (403)

Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis. [PDF]

open access: yes, 2010
Epidemiological studies have shown that one of the strongest risk factors for prostate cancer is a family history of the disease, suggesting that inherited factors play a major role in prostate cancer susceptibility.
Ashworth, Alan   +4 more
core   +3 more sources

INFLUENCE OF THE CTLA-4 (RS231775) GENE POLYMORPHISM ON THE DEGREE OF THE THYROID GLAND ENLARGEMENT IN PATIENTS OPERATED FOR NODULAR GOITER SECONDARY TO AUTOIMMUNE THYROIDITIS [PDF]

open access: yesArchives of the Balkan Medical Union, 2017
Objectives: To analyze the influence of the CTLA-4(+49G/A)rs231775 gene polymorphism on the degree of thyroid gland enlargement in patients operated for nodular goiter secondary to autoimmune thyroiditis (NGAIT) and thyroid adenomas (TA).
Michael I. Sheremet   +11 more
doaj  

Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma

open access: yesIndian Journal of Urology, 2008
Aim: Atypical adenomatous hyperplasia (AAH) is a small glandular proliferation that has histological similarities with Gleason grade 1 and 2 prostatic adenocarcinoma (PACG1,2).
Ahmet Midi   +3 more
doaj   +1 more source

Normocalcemic non-renal hyperparathyroidism

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2022
Parathyroid hormone (PTH) is produced by the parathyroid glands, which are the main regulators of calcium and phosphorus metabolism. Hyperparathyroidism is a clinical condition associated with an increase in serum PTH content.
O.V. Kaminskyi, Yu.O. Kaminskа
doaj   +1 more source

Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2019
Progestogens are widely used for the conservative treatment of endometrial hyperplasia and early endometrial cancer. Nevertheless, they do not achieve the regression in all cases. Although several immunohistochemical markers have been assessed to predict
A. Travaglino   +6 more
semanticscholar   +1 more source

Preleukemia: hematological disorders prior to onset of leukemia [PDF]

open access: yes, 1975
Published data on Japanese leukemia patients with a preleukemic hematological disorder were assessed. The reexamined cases were from the "Japona Centra Revuo Medicina" reported during the period from 1952 to 1971.
Hiraki, Kiyoshi   +5 more
core   +1 more source

Idiopathic noncirrhotic portal hypertension: current perspectives [PDF]

open access: yes, 2016
The term idiopathic noncirrhotic portal hypertension (INCPH) has been recently proposed to replace terms, such as hepatoportal sclerosis, idiopathic portal hypertension, incomplete septal cirrhosis, and nodular regenerative hyperplasia, used to describe ...
D'AMATI, Giulia   +5 more
core   +1 more source

Pigmentary keratitis and mixed chromatophoroma in a betta fish (Betta splendens)

open access: yesAquaculture, Fish and Fisheries, Volume 2, Issue 6, Page 587-592, December 2022., 2022
Graphical Abstract This clinical case report describes a <1 year old betta fish that developed pigmentary keratitis, anterior uveitis, and a mixed chromatophoroma that led to the patient's death. A review of available anecdotal and scientific literature suggests that there may have been a genetic cause for these health problems.
Alicia McLaughlin   +3 more
wiley   +1 more source

Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?

open access: yesJournal of Obstetrics and Gynaecology, 2023
It is not standardised what is the endometrial thickness that discriminates between normal and potentially malignant. The objective of this study was to determine the endometrial thickness cut-off point from which the risk of endometrial cancer (EC ...
Alba María Cruz García   +8 more
doaj   +1 more source

PEA‐15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia [PDF]

open access: yes, 2017
This work was supported by a grant from the Medical Research Council, UK (MR/K012789/1).
Gibson, George   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy